Nationwide Fund Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-44,892
| Closed | -$673K | – | 1741 |
|
|
2017
Q3 | $673K | Buy |
44,892
+5,337
| +13% | +$80K | ﹤0.01% | 2020 |
|
|
2017
Q2 | $348K | Hold |
39,555
| – | – | ﹤0.01% | 2364 |
|
|
2017
Q1 | $206K | Sell |
39,555
-4,834
| -11% | -$25.2K | ﹤0.01% | 2572 |
|
|
2016
Q4 | $135K | Hold |
44,389
| – | – | ﹤0.01% | 2769 |
|
|
2016
Q3 | $206K | Hold |
44,389
| – | – | ﹤0.01% | 2605 |
|
|
2016
Q2 | $257K | Hold |
44,389
| – | – | ﹤0.01% | 2496 |
|
|
2016
Q1 | $269K | Sell |
44,389
-1,894
| -4% | -$11.5K | ﹤0.01% | 2402 |
|
|
2015
Q4 | $423K | Buy |
46,283
+1,165
| +3% | +$10.6K | ﹤0.01% | 2192 |
|
|
2015
Q3 | $254K | Hold |
45,118
| – | – | ﹤0.01% | 2451 |
|
|
2015
Q2 | $500K | Sell |
45,118
-4,648
| -9% | -$51.5K | ﹤0.01% | 2246 |
|
|
2015
Q1 | $780K | Sell |
49,766
-1,859
| -4% | -$29.1K | ﹤0.01% | 2016 |
|
|
2014
Q4 | $785K | Sell |
51,625
-633
| -1% | -$9.63K | ﹤0.01% | 1930 |
|
|
2014
Q3 | $564K | Sell |
52,258
-72
| -0.1% | -$777 | ﹤0.01% | 2139 |
|
|
2014
Q2 | $799K | Buy |
52,330
+3,421
| +7% | +$52.2K | ﹤0.01% | 2011 |
|
|
2014
Q1 | $884K | Buy |
48,909
+1,807
| +4% | +$32.7K | ﹤0.01% | 1794 |
|
|
2013
Q4 | $654K | Buy |
47,102
+2,357
| +5% | +$32.7K | ﹤0.01% | 2111 |
|
|
2013
Q3 | $469K | Buy |
44,745
+275
| +0.6% | +$2.88K | ﹤0.01% | 2255 |
|
|
2013
Q2 | $347K | Buy |
+44,470
| New | +$347K | ﹤0.01% | 2214 |
|